PM360

JUNE 11, 2022

Only 5% of patients ranked pharma companies as the most trusted player in the healthcare space, according to a 2021 survey of 500 patients from Accenture. But 71% also want publicly shared information about how patients’ perspectives were incorporated into the development of products and services. Noël Moossa.

Patients 59

Patients Pharma Education Media 59

pharmaphorum

JANUARY 10, 2023

As two in five pharma leaders say that moving to a consumer-first mindset is a priority for the next two years, digital customer experience agency Graphite Digital is to publish a special edition of its Contradiction Conundrum whitepaper report, released in partnership with Reuters Events Pharma last year.

Pharma 52

Pharma Specialization Sales Biopharma 52

Medico Reach

AUGUST 1, 2022

Whether you are a start-up looking for investment or are interested in working in venture capital (VC), the worldwide biopharma and MedTech industries are growing. In 2022, over $14 billion was funded in biopharma setup globally, and 37 major IPOs of VC-backed biotech company businesses raised a combined $4.2 The Venture Capitals.

Biopharma 52

Biopharma Healthcare Healthcare Specialization 52

pharmaphorum

OCTOBER 18, 2022

Oculis SA, a global biopharmaceutical company that develops treatments for saving sight and improving eye care with breakthrough innovations, is to combine with the European Biotech Acquisition Corp (EBAC), a special purpose acquisition company (SPAC) that has screened over 100 European biotechnology companies.

Biopharma 57

Biopharma Management Specialization Physicians 57

Clarivate

MAY 24, 2022

Recent policy and regulatory moves have begun to sketch out a framework for rare disease drug approvals in the country, but obstacles to approvals and patient access remain. Mainland China has taken significant steps toward improving access to treatment for its estimated 20 million rare disease patients in recent years. [1]

Patients 52

Patients Food and Drug Administration Marketing Pharma 52

The Marketing Advantage

MAY 8, 2023

May 9, 2023 Since the Orphan Drug Act was passed in 1983, the number of products being researched and approved for rare and orphan diseases has increased dramatically, offering hope and life-saving treatments for the millions of patients affected by these often under-served conditions.

Sales 52

Sales Physicians Consulting Education 52

Pharma Marketing Network

MARCH 25, 2022

Although the caregiver is seen as an extension of the patient and their role is not strictly defined, they are informal members of the front-line care team. Caregiver observations of the patient experience over the progression of the disease may inform the safety and efficacy of a particular therapeutic. Accessed March 12, 2022.

Pharma 98

Pharma Education Transportation Training 98

Clarivate

APRIL 19, 2024

7] FLLs are often found incidentally during imaging for other purposes, such as the assessment of abdominal pain or during surveillance for liver metastases in patients with non-liver cancer. [8] 22] They are also performed in a dedicated room, where the patient is confined to a large scanner on their own and may experience discomfort. [24]

Medical 59

Medical Patients Specialization Healthcare 59

PM360

OCTOBER 5, 2023

Now, Real Chemistry is at the forefront of applying analytics, data, and artificial intelligence to the biopharma and healthcare industry and, in 2022, the company achieved its 21st consecutive year of double-digit growth. Director US Marketing and Patient Engagement, argenx US, Inc. Cardiology: Bradley A.

Education 52

Education Marketing Media Biopharma 52

pharmaphorum

JULY 27, 2022

Demerging Haleon has allowed GSK to focus on higher-margin prescription medicines and vaccines, as well as provide cash for investment in its biopharma pipeline. GSK has already made moves in this direction this year with deals to buy cancer specialist Sierra Oncology for $1.9 billion and vaccine firm Affinivax for up to $3.3

Sales 52

Sales Biopharma Prescription Medicine 52

PM360

AUGUST 24, 2023

Each of their trailblazing efforts result in much more than personal or organization success, it results in better quality of life for patients, better care options for healthcare providers, and happier and healthier people around the world.” Director US Marketing and Patient Engagement, argenx US, Inc. Braun Medical, Inc.

Marketing 52

Marketing Education Media Healthcare 52

MedCity News

JUNE 16, 2023

Investors in 2022 appeared confident that the continued transformation of drug research and development protocols and the overall life sciences industry will not only include digital health solutions, but will even depend on them for data collection, analysis, patient engagement, and even their therapeutic properties.

Pharma 113

Pharma Food and Drug Administration Recruitment Pharmacology 113

Eversana Intouch

FEBRUARY 23, 2023

Historically, the pharmaceutical industry is economically sturdy, but three things are not: patients’ household budgets, marketing department budgets, and small-company budgets. Biopharma valuations are down, especially for public and earlier-stage companies. Implications of economic volatility abound: Patients: Market access gaps.

Marketing 52

Marketing Pharma Patients Insurance 52

Eversana Intouch

FEBRUARY 23, 2023

Historically, the pharmaceutical industry is economically sturdy, but three things are not: patients’ household budgets, marketing department budgets, and small-company budgets. Biopharma valuations are down, especially for public and earlier-stage companies. Implications of economic volatility abound: Patients: Market access gaps.

Marketing 52

Marketing Pharma Patients Insurance 52

Pharmaceutical Technology

FEBRUARY 28, 2023

Breakthroughs in therapies containing monoclonal antibodies (mAbs) are showing ever-greater potential in treating a range of diseases, alongside biopharma manufacturers facing the challenge of keeping up with demand for production while controlling costs. This can result in reductions in costs for our customers.” Download to learn more.

Biopharma 94

Biopharma Manufacturing Training Specialization 94

Pharma Marketing Network

JANUARY 12, 2023

Advancing medicine, advancing patient care, and advancing equity in our global workforce are shared values of this year’s honorees driving transformational change and impact,” said Wendy White, interim CEO and 2022 STAR, HBA. These experiences have empowered Christi to become a leading industry voice advocating fiercely for patients.

Healthcare 52

Healthcare Healthcare Networking Manufacturing 52

Clarivate

MAY 11, 2023

Mainland China has streamlined regulatory protocols for testing and approving prescription drugs in recent years, making dozens of urgently needed treatments, from domestic and international manufacturers alike, available to patients in the process. In parallel, the CDE also established a special channel to facilitate these approvals.

Marketing 52

Marketing Patients Management Insurance 52

Pharmaceutical Technology

JUNE 15, 2023

Learn about how AI is helping companies right now, what to know about its benefits and challenges, and what’s needed to implement AI in biopharma research. Clinical trial monitoring Completing clinical studies more quickly can mean critical medicines and treatments reach patients faster. How is AI used in the pharmaceutical industry?

Pharma 52

Pharma Management Networking Manufacturing 52

Clarivate

DECEMBER 6, 2022

These health systems combine multiple sites and services, and sometimes a health maintenance organization, to provide end-to-end care to patients locally or regionally. states and the United Kingdom and sees more than 35 million patient encounters per year. Beyond the biggest players, however, there are a number of IDNs that stand out.

Networking 52

Networking Healthcare Healthcare Competition 52

PM360

NOVEMBER 21, 2022

Many of biopharma’s most exciting innovations come from the field of rare and ultra-rare diseases like Marc’s. With the development of new technology platforms at breakneck speed, companies are positioning themselves to one day deliver game-changing solutions to patients in their niche—solutions they may have been waiting for all their life.

Patients 52

Patients Medicine Biopharma Media 52

Pharmaceutical Technology

MARCH 22, 2023

The appeal of process intensification continues to grow in the biopharma industry as a means of not only increasing the productivity, but also improving sustainability. Patients living with cancer and Alzheimer’s are two examples of groups that need access. Yet this is far from straightforward. Download to learn more.

Biopharma 52

Biopharma Manufacturing Engineering Specialization 52

Pharmaceutical Technology

JANUARY 20, 2023

The demand for mAbs is increasing as they offer patients targeted treatments for a wide range of serious health conditions and diseases. Nevertheless, the potential for mAb therapies in treating medical conditions that have limited options means that biopharma companies are investing considerable resources in development.

Biopharma 52

Biopharma Manufacturing Specialization Engineering 52

PM360

JUNE 30, 2022

Now, the two companies will unite their full suite of advisory, medical, marketing, communications, and patient and stakeholder engagement services to create a new organization called Inizio. The unit will specialize in medical communications, medical affairs, real-world evidence, and outcomes research.

Specialization 97

Specialization Consulting Healthcare Healthcare 97

Clarivate

MAY 24, 2023

Food and Drug Administration advisory committee’s narrow 8-6 vote in favor of recommending accelerated approval for a first-in-class gene transfer therapy was welcomed by Duchenne muscular dystrophy (DMD) patients and caregivers. Most patients must use a wheelchair by the time they are in their teens.

Patients 52

Patients Food and Drug Administration Biopharma FDA 52

pharmaphorum

JANUARY 11, 2023

The research solutions cluster came second, with 15% of the total (just over $5 billion) – marked by a $300 million third round for Chinese bioinformatics firm Enzymaster – with patient solutions at 11% ($3.6 Roche tops biopharma partnering podium. billion) led by a $300 million Series E for connected kidney care specialist Somatus.

Biopharma 68

Biopharma Specialization Physicians Healthcare 68

European Pharmaceutical Review

OCTOBER 2, 2023

Eligible companies classified as start-ups and active in the pharma, biopharma, digital, or medical device sectors can exhibit. This special edition will introduce three new categories, acknowledging the remarkable wave of innovation that has engulfed the industry. Patient Centric Development , and Quality Management Fundamentals.

Manufacturing 99

Manufacturing Pharma Engineering Networking 99

PM360

JUNE 16, 2023

Francis Pang, Global Head of Market Access at Orchard Therapeutics noted that “payers globally want a menu of innovative pricing mechanisms: guaranteed outcomes, pay for performance, long duration of risk sharing, tiered pricing, and caps on the number of patients and doses.” Global patient access extends that white glove support worldwide.

Marketing 98

Marketing Management Insurance Specialization 98

Pharmaceutical Technology

MAY 24, 2023

The ability to modify or introduce genetic material in human cells in such a precise and patient-centered manner clearly constitutes a breakthrough in personalized medicine. Allogeneic therapies begin with healthy donor samples to develop the eventual therapeutic product which can be administered to multiple patients.

Manufacturing 98

Manufacturing Transportation Specialization Patients 98

Pharmaceutical Technology

AUGUST 26, 2008

“The inherent advantages of biopharma are that it allows you to pursue therapies against targets that are not small molecule therapies, for example by targeting protein-protein interactions and targeting GPCRs (G-protein coupled receptors),” he says. “Biotechnology has exploded across the industry. .

Manufacturing 52

Manufacturing Pharmaceutical Biopharma Medicine 52

European Pharmaceutical Review

DECEMBER 21, 2022

His special interests are in the field of chemical policy and sustainable chemistry. Delivering cellular and gene therapies to patients: solutions for realizing the potential of the next generation of medicine. Biopharma successful in achieving climate-related goals, report finds … . References: Elverum K, Whitman M.

Manufacturing 77

Manufacturing Pharmaceutical Healthcare Healthcare 77

Medgadget

MARCH 2, 2023

Special software that takes DICOM images from CT scanners and creates a treatment plan, defines the distribution of the Alpha DaRT sources within the tumor. The rest of the patients had partial responses. with ten patients to try to duplicate the results. which are currently recruiting patients.

Manufacturing 83

Manufacturing Leads Patients Medicine 83

Pharmaceutical Technology

APRIL 24, 2023

Because biologics work with live cells, manufacturing them is difficult, and highly specialized facilities and infrastructure are needed. Free Whitepaper Choosing the ‘right’ CRO/CDMO in Biopharma: What has changed? Biopharma outsourcing has rapidly developed.

Manufacturing 52

Manufacturing Food and Drug Administration Biopharma Sales 52

Pharmaceutical Technology

MARCH 20, 2023

These high rates of diseases in largely untapped patient pools, present invaluable opportunities to trial new drugs that can help people living with chronic conditions and battling serious illnesses. of patients who take part in clinical trials are from a Caucasian background, which rises further to 84.2% being African American, 3.4%

Distribution 52

Distribution Management Patients Transportation 52

Pharmaceutical Technology

JANUARY 25, 2023

Although expert opinions differ on the future of special purpose acquisition companies (SPACs), some companies are continuing to explore their use. In December 2022, AEON Biopharma, a biopharmaceutical company, announced its plans to go public through a merger with the SPAC Priveterra Acquisition Corp.

Marketing 69

Marketing Biopharma Pharma Competition 69